I am/have/had
I am looking for
Advanced Filters
Found 284 clinical trials
Featured trial
MagnetisMM-5—for people who have tried atleast two prior treatments
A phase 3 study known as MagnetisMM-5 is looking for around 820 participants with relapsed/refractory multiple myeloma. The study will allow us to learn more about how a study medicine, called elranatamab, works alone and in combination with a medicine called daratumumab compared to a current standard treatment (a combination …
- 0 views
- 26 Jun, 2024
- 1 location
